PACB Jan 2024 25.000 call
| Previous Close | 0.4800 |
| Open | 0.4800 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 25.00 |
| Expire Date | 2024-01-19 |
| Day's Range | 0.4800 - 0.4800 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
- GlobeNewswire
PacBio Grants Equity Incentive Award to New Employee
MENLO PARK, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 50,000 shares of PacBio common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity
- GlobeNewswire
Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer
Genomics Veteran to Lead Company Which Has a Commercial-Ready Novel Technology Platform that Can Realize the Largely Untapped Contribution of Epigenetics to Human Health Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer Genomics Veteran to Lead Company Which Has a Commercial-Ready Novel Technology Platform that Can Realize the Largely Untapped Contribution of Epigenetics to Human Health CAMBRIDGE, United Kingdom, June 14, 2022 (GLOBE NEWSWIRE) -- Cambridge Epigenetix (CEGX), a l
- Simply Wall St.
Pacific Biosciences of California (NASDAQ:PACB) dips 18% this week as increasing losses might not be inspiring confidence among its investors
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...
